Search

Your search keyword '"Uro-Coste, Emmanuelle"' showing total 344 results

Search Constraints

Start Over You searched for: Author "Uro-Coste, Emmanuelle" Remove constraint Author: "Uro-Coste, Emmanuelle" Language english Remove constraint Language: english
344 results on '"Uro-Coste, Emmanuelle"'

Search Results

1. FGFR1 wild-type rosette-forming glioneuronal tumours

2. CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas

3. PLAG1 fusions extend the spectrum of PLAG(L)-altered CNS tumors

5. CNS neuroblastoma, FOXR2-activated and its mimics: a relevant panel approach for work-up and accurate diagnosis of this rare neoplasm

6. CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population

8. Beneath HMGA2 alterations in pleomorphic adenomas: Pathological, immunohistochemical, and molecular insights

9. Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours

11. Clinicopathological and molecular characterization of three cases classified by DNA-methylation profiling as “Glioneuronal Tumors, NOS, Subtype A”

12. Survival outcomes, prognostic factors, and effect of adjuvant radiotherapy and prophylactic neck dissection in salivary acinic cell carcinoma: A prospective multicenter REFCOR study of 187 patients

14. Natural Course and Prognosis of Primary Spinal Glioblastoma: A Nationwide Study

15. Disseminated diffuse midline gliomas, H3K27-altered mimicking diffuse leptomeningeal glioneuronal tumors: a diagnostical challenge!

16. PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum

17. Mucoepidermoid carcinoma of salivary glands: A French Network of Rare Head and Neck Tumors (REFCOR) prospective study of 292 cases

18. Evaluating next-generation sequencing in neuromuscular diseases with neonatal respiratory distress

20. A recurrent RYR1 mutation associated with early-onset hypotonia and benign disease course

21. The molecular landscape of ETMR at diagnosis and relapse

23. Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial).

24. 849: Relapse Risk stratification in pediatric ependymoma patients using clinical data and radiomics

25. Two novel tumours with NTRK2 fusion in the methylation class of extraventricular neurocytomas, including one intraventricular.

27. The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of “CNS tumors with BCOR internal tandem duplication”

29. ETMR-like infantile cerebellar embryonal tumors in the extended morphologic spectrum of DICER1-related tumors

30. Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases

31. Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging

32. Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort

33. HPV-related Multiphenotypic Sinonasal Carcinoma: An Expanded Series of 49 Cases of the Tumor Formerly Known as HPV-related Carcinoma With Adenoid Cystic Carcinoma-like Features

34. A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas.

36. Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co‐deleted anaplastic gliomas

37. ETV4 immunohistostaining is a sensitive and specific diagnostic biomarker for CIC‐rearranged sarcoma of the central nervous system.

39. Prognostic Relevance of Histomolecular Classification of Diffuse Adult High-Grade Gliomas with Necrosis

43. Radiotherapy‐PCV versus radiotherapy‐temozolomide for IDH ‐mutant anaplastic astrocytoma: a retrospective multicentre analysis of the French POLA cohort

44. Rosette‐forming glioneuronal tumours are midline, FGFR1‐mutated tumours.

46. Recessive TTN truncating mutations define novel forms of core myopathy with heart disease

48. NCOA4-RET and TRIM27-RET are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is 'Intraductal' Correct?

49. Low‐grade epilepsy‐associated neuroepithelial tumours with a prominent oligodendroglioma‐like component: The diagnostic challenges.

50. An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB‐fused broadening the spectrum of tumor entities in comparison with their soft tissue counterparts.

Catalog

Books, media, physical & digital resources